第六届监事会第十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300165 证券简称：ST天瑞 公告编号：2025-012 江苏天瑞仪器股份有限公司 一、监事会会议召开情况 江苏天瑞仪器股份有限公司（以下简称"公司"）于 2025 年 4 月 13 日以电 子邮件方式向全体监事发出召开第六届监事会第十一次会议的通知，会议于2025 年 4 月 24 日上午 10：00 在公司八楼会议室以现场会议的方式召开。会议应出席 监事 3 人，实际出席监事 3 人。董事会秘书肖廷良列席会议。会议由监事会主席 郑朝召集和主持，会议的召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 二、监事会会议审议情况 经全体监事认真审议，形成决议如下： 1、审议通过了《2024 年度监事会工作报告》 《2024 年度监事会工作报告》详见中国证券监督管理委员会（以下简称"中 国证监会"）指定创业板信息披露网站巨潮资讯网（www.cninfo.com.cn）。 本议案以 3 票同意、0 票反对、0 票弃权的表决结果获得通过。 本议案需提交 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-013 江苏天瑞仪器股份有限公司 关于 2024 年度拟不进行利润分配的专项说明 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 江苏天瑞仪器股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日分别 召开了第六届董事会第十四次会议和第六届监事会第十一次会议，审议通过了 《关于 2024 年度利润分配预案的议案》，本议案尚需提交公司 2024 年年度股东 大会审议，现将有关情况公告如下： 一、2024 年度利润分配的基本情况 经公证天业会计师事务所（特殊普通合伙）（以下简称"公证天业"）审计 确认，公司 2024 年 度 合 并 报 表 实 现 归 属 于 上 市 公 司 股 东 的 净 利 润 为 -97,318,864.53 元，其中母公司实现净利润为 47,604,119.07 元。截至 2024 年 12 月 31 日，合并报表累计未分配利润为-60,348,416.85 元，母公司累计未分配 利润为 564,938,101.70 元。 为保障公司正常生产经营和未来发展，依据《 ...

Financial Performance - The net profit attributable to shareholders of the listed company for 2024 was -97.3189 million yuan, a year-on-year reduction in losses of 14.95%[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -99.3188 million yuan, a year-on-year reduction in losses of 15.90%[3]. - The primary reason for the losses was significant credit impairment and asset impairment provisions made by subsidiaries[3]. - The company's operating revenue for 2024 was ¥851,122,143.12, a decrease of 16.33% compared to ¥1,017,212,385.17 in 2023[18]. - The net profit attributable to shareholders for 2024 was -¥97,318,864.53, an improvement of 14.95% from -¥114,432,116.75 in 2023[18]. - The cash flow from operating activities for 2024 was ¥110,994,114.72, a significant increase of 154.85% compared to -¥202,352,290.56 in 2023[18]. - The total assets at the end of 2024 were ¥3,426,462,827.56, down 8.78% from ¥3,756,441,828.51 at the end of 2023[18]. - The net assets attributable to shareholders at the end of 2024 were ¥1,276,868,449.30, a decrease of 7.79% from ¥1,384,727,884.10 at the end of 2023[18]. - The company reported a basic earnings per share of -¥0.20 for 2024, an improvement of 13.04% from -¥0.23 in 2023[18]. Research and Development - The company plans to increase R&D investment to enhance technological innovation and improve its industry position and business competitiveness[3]. - Research and development investment for the reporting period was 72.59 million yuan, a decrease of 17.56% compared to the previous year, amounting to a reduction of 15.46 million yuan[106]. - The number of R&D personnel decreased by 57.49% from 581 in 2023 to 247 in 2024, with a notable drop in the proportion of R&D staff from 31.73% to 14.92%[124]. - The company aims to strengthen its industry position and sustainable development capabilities through increased R&D efforts[106]. - The company is focusing on the development of new technologies, including a controllable high-voltage power supply and advanced gas chromatography systems[62]. Market and Competitive Position - The company’s core business and competitive strengths have not undergone significant adverse changes[3]. - The company aims to improve operational performance through enhanced R&D and sustainable development efforts[3]. - The company is transitioning from a single analytical instrument supplier to a comprehensive analytical detection service provider, expanding into new industries and applications[37]. - The company has maintained a strong emphasis on independent innovation, increasing R&D investment and expanding its product line, ensuring its leadership position in the domestic analytical instrument sector[59]. - The company is actively pursuing market expansion through the introduction of new products and technologies, aiming to capture a larger market share[65]. Environmental Governance and Sustainability - The environmental governance sector is also a focus for the company, supported by government policies promoting ecological civilization[29]. - The company is well-positioned to benefit from national support for environmental protection and pollution prevention initiatives, aligning with its business focus[36]. - The company’s environmental services cover industrial wastewater, municipal sewage, solid waste treatment, and soil and groundwater remediation, showcasing a comprehensive service model[52]. - The company has developed a new ozone catalytic oxidation technology for wastewater treatment, which can achieve surface water Class V standards, indicating a significant market potential[105]. Acquisitions and Investments - The company plans to invest $50 million in research and development over the next two years to accelerate innovation[63]. - A new acquisition strategy is being implemented, with a goal to acquire at least two complementary businesses within the next 18 months[63]. - The company has completed the acquisition of Suzhou Tianrui Environmental Technology Co., Ltd. for 9,720 million, representing a 100% ownership stake[137]. - The company successfully acquired Shanghai Bexi Biotechnology Co., Ltd. for 36,000 million, achieving full ownership[137]. - The company is focusing on mergers and acquisitions as a key strategy for growth in the upcoming fiscal year[137]. Operational Efficiency - The company emphasizes strict procurement management, establishing long-term relationships with key suppliers to ensure material quality[55]. - The company utilizes an ERP system for unified planning of production and procurement, ensuring efficient manufacturing processes[56]. - The company aims to improve operational efficiency by 12% through the implementation of advanced manufacturing technologies[63]. - The company has achieved significant operational management increases, with the research and development center reporting a 111.77% increase[137]. Risks and Challenges - The company faces risks related to PPP projects, including delayed payments and potential impacts from macroeconomic conditions[6]. - The company emphasizes the importance of understanding the risks associated with forward-looking statements and plans[4]. - The company reported a significant asset impairment loss of 61.47 million yuan, accounting for 66.80% of total profit, primarily due to inventory write-downs and goodwill impairment[128]. Revenue Breakdown - Instrument manufacturing industry revenue increased by 1.15% to ¥546,543,120.44, accounting for 64.21% of total revenue[107]. - Revenue from ecological protection and environmental governance decreased by 46.45% to ¥199,591,708.93, representing 23.45% of total revenue[107]. - Third-party testing revenue increased by 7.59% to ¥88,695,225.21, making up 10.42% of total revenue[107]. - Direct sales accounted for 89.53% of total revenue, decreasing by 19.14% compared to the previous year[109]. Software and Technology Development - The company has obtained 216 software copyright registration certificates as of the reporting period[83]. - The company has developed multiple software applications for environmental monitoring, including air quality and water quality analysis, with original acquisition dates ranging from 2011 to 2019[86][87]. - The company has launched a mobile monitoring system for atmospheric pollutants, which was registered on November 16, 2020, reflecting its focus on innovative monitoring solutions[89]. - The company has developed a comprehensive groundwater management platform software, which was registered on October 26, 2022, to enhance water resource management[89]. Future Outlook - Future outlook includes a projected revenue growth of 15% for the next fiscal year, driven by new product launches and market expansion strategies[63]. - The overall performance outlook for the next quarter indicates a strong growth trajectory, driven by strategic investments and acquisitions[137].

Financial Performance - The company's revenue for Q1 2025 was ¥128,489,419.49, a decrease of 5.85% compared to ¥136,466,186.01 in the same period last year[5] - Net profit attributable to shareholders was ¥3,163,218.13, representing a significant increase of 137.31% from a loss of ¥8,478,825.34 in the previous year[5] - Basic earnings per share rose to ¥0.01, a 150.00% increase from a loss of ¥0.02 per share in the same period last year[5] - The net profit for the current period is 1,549,729.64, compared to a net loss of 8,357,695.27 in the previous period, indicating a significant recovery[25] - The total profit for the current period is 3,831,890.19, while the previous period recorded a total loss of 7,952,895.94, showing a turnaround in financial performance[25] Cash Flow - The net cash flow from operating activities improved to ¥19,929,376.72, a remarkable increase of 216.92% compared to a negative cash flow of ¥17,045,952.67 last year[5] - Operating cash flow net amount is 19,929,376.72, a substantial improvement from the negative cash flow of -17,045,952.67 in the previous period[27] - Cash flow from investment activities shows a net inflow of 7,429,570.90, compared to a net outflow of -3,402,497.57 in the previous period, reflecting better investment management[28] - Cash flow from financing activities resulted in a net outflow of -41,368,597.13, contrasting with a net inflow of 15,696,964.91 in the previous period, indicating increased debt repayment[28] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥3,401,032,253.76, a slight decrease of 0.74% from ¥3,426,462,827.56 at the end of the previous year[5] - Total liabilities decreased to CNY 2,073,883,949.96 from CNY 2,101,346,449.07, a reduction of 1.3%[23] - The total equity attributable to shareholders increased slightly to CNY 1,280,513,863.10 from CNY 1,276,868,449.30, an increase of 0.3%[23] - The company reported a total non-current asset of CNY 379,520,424.58, down from CNY 401,309,206.09, a decrease of 5.4%[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 19,207[15] - The largest shareholder, Liu Zhaogui, holds 16.13% of shares, totaling 79,914,203 shares[15] - The second largest shareholder, Guangzhou Lidu Virtual Reality Technology Partnership, holds 5.01% of shares, totaling 24,825,137 shares[15] - The total number of shares held by the top ten unrestricted shareholders is 24,825,137 shares, all of which are common shares[16] Research and Development - Research and development expenses decreased by 55.18% to ¥943.12 million from ¥2,104.10 million in the previous year, mainly due to the completion of certain projects[11] - Research and development expenses significantly decreased to CNY 9,431,248.52 from CNY 21,040,990.78, a decline of 55.2%[24] Inventory and Receivables - The company reported a significant increase in accounts receivable by 43.88% to ¥22,713.90 million, attributed to an increase in accepted bills[10] - Accounts receivable decreased from 511,897,399.35 RMB to 464,339,807.45 RMB, a reduction of approximately 9.3%[21] - Inventory increased from 355,551,963.16 RMB to 363,483,524.89 RMB, an increase of approximately 2.6%[21] Regulatory and Compliance - The company is under administrative penalties from the China Securities Regulatory Commission, with risk warnings effective from December 10, 2024[20] - The company plans to apply for the removal of risk warnings after meeting specific conditions related to financial reporting[20] Other Financial Metrics - Investment income surged by 736.21% to ¥77.60 million compared to ¥9.28 million in the same period last year, primarily due to increased returns from joint ventures[11] - Total operating costs decreased to CNY 111,835,825.29 from CNY 146,220,580.29, reflecting a reduction of 23.4%[24] - The company incurred credit impairment losses of -13,099,645.15, which is an increase from -1,857,314.80 in the previous period, indicating rising credit risk[25] - The company did not report any net profit from subsidiaries prior to the merger, consistent with the previous period[26]

公司于2024年12月6日收到中国证监会出具的《行政处罚事先告知书》，根据 《行政处罚事先告知书》认定的情况，公司涉及的违法违规行为触及《深圳证券 交易所创业板股票上市规则（2024年修订）》第9.4条第（七）项规定的被实施其 他风险警示情形，公司股票于2024年12月10日起被实施其他风险警示，具体内容 详见公司在巨潮资讯网上披露的《关于公司股票交易被实施其他风险警示暨股票 停复牌的提示性公告》（公告编号：2024-074）。 证券代码：300165 证券简称：ST天瑞 公告编号：2025-007 江苏天瑞仪器股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、江苏天瑞仪器股份有限公司（以下简称"公司"）收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》（公告编号：2024-073）。根据《深圳证券交 易所创业板股票上市规则（2024年修订）》第9.4条第（七）项规定，公司股票 于2024年12月10日 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-006 江苏天瑞仪器股份有限公司 关于公司及相关当事人收到《行政处罚决定书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2025年3月18日，公司及相关当事人收到中国证监会出具的《行政处罚决定 书》（[2025]40号），现将相关内容公告如下： 二、《行政处罚决定书》主要内容 当事人：江苏天瑞仪器股份有限公司(以下简称天瑞仪器)，住所:江苏省昆 山市中华园西路1888号。 刘召贵，男，1962年11月出生，时任天瑞仪器董事长，住址:江苏省昆山市 ***。 吴照兵，男，1963年3月出生，时任天瑞仪器财务总监，住址:江苏省昆山市 ***。 张鑫，男，1976年5月出生，时任天瑞仪器独立董事、审计委员会主任，住 址:江苏省昆山市***。 一、基本情况 江苏天瑞仪器股份有限公司（以下简称"天瑞仪器"或"公司"）于2024年4 月25日收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《中国证 券监督管理委员会立案告知书》（证监立案字0382024015号），因公司涉嫌信息 披露违法违 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-005 江苏天瑞仪器股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 3、根据《深圳证券交易所创业板股票上市规则（2024年修订）》9.11条， "公司同时符合下列条件的，可以向本所申请对其股票交易撤销其他风险警示： （一）公司已就行政处罚决定所涉事项对相应年度财务会计报告进行追溯重述； （二）自中国证监会作出行政处罚决定书之日起已满十二个月。"公司将在满足 上述条件后及时提出申请，争取尽早撤销风险警示。 特别提示： 1、江苏天瑞仪器股份有限公司（以下简称"公司"）收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》（公告编号：2024-073）。根据《深圳证券交 易所创业板股票上市规则（2024年修订）》第9.4条第（七）项规定，公司股票 于2024年12月10日起被实施其他风险警示。 2、根据《深圳证券交易所创业板股票上市规则（2024年修订）》第9.9条 规定，公司因触及第9.4条第七项情形，其股票交易被实施其他风险警示期间， 应当至少每月披露一次 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-004 江苏天瑞仪器股份有限公司 关于变更保荐代表人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 江苏天瑞仪器股份有限公司董事会 二○二五年二月十九日 附件：保荐代表人王克宇先生简历 王克宇：申港证券投资银行部保荐代表人，律师，管理学硕士，长江商学院 EMBA。曾先后主持或参与了东吴证券（601555）非公开发行、蓝丰生化（002513）、 金螳螂（002081）、鲁信创投（600783）、亨通光电（600487）、ST 兰光（000981）、 太工天成（600392）、ST 国通（600444）重大资产重组、秦川机床（000837）非 公开发行、科创板上市公司阿拉丁（688179）IPO 保荐发行等项目。 江苏天瑞仪器股份有限公司（以下简称"公司"）于近日收到公司首次公开 发行股票剩余募集资金持续督导机构"申港证券股份有限公司"（以下简称"申 港证券"）《关于更换江苏天瑞仪器股份有限公司持续督导保荐代表人的函》。申 港证券原委派的保荐代表人蔡磊宇因工作变动，不再担任公司持续督导工作的保 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-003 江苏天瑞仪器股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2、公司收到《行政处罚事先告知书》后立即采取行动，组织财务等各相关 部门以及年审会计师事务所工作人员就《行政处罚事先告知书》涉及的情况进 行仔细梳理。如果仍然存在尚未整改完毕的事项，公司将依法履行相关信息披 露义务。 3、根据《深圳证券交易所创业板股票上市规则（2024年修订）》9.11条， "公司同时符合下列条件的，可以向本所申请对其股票交易撤销其他风险警示： （一）公司已就行政处罚决定所涉事项对相应年度财务会计报告进行追溯重述； （二）自中国证监会作出行政处罚决定书之日起已满十二个月。"公司将在满足 上述条件后及时提出申请，争取尽早撤销风险警示。 三、对公司的影响及风险提示 1、江苏天瑞仪器股份有限公司（以下简称"公司"）收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》（公告编号： ...

Financial Performance - The company expects a net loss for the fiscal year 2024, estimated between RMB 65 million and RMB 95 million[3]. - The net loss after deducting non-recurring losses is projected to be between RMB 68 million and RMB 98 million, compared to a loss of RMB 114.43 million in the same period last year[4]. Credit Risk and Impairment - The increase in credit risk is attributed to the deteriorating credit status of some customers, leading to higher provisions for credit impairment losses[6]. - The company anticipates goodwill impairment of approximately RMB 30 million to RMB 35 million for its subsidiaries, based on prudent assessments of their future prospects[6]. - The final amount of impairment provisions will be determined after evaluation by a professional assessment agency and the annual audit firm[7]. Reporting and Disclosure - The preliminary financial data for 2024 will be disclosed in detail in the company's annual report[8].